Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Manhattan Associates Inc (MANH) vs UnitedHealth Group Inc (UNH) Price & Performance

Manhattan Associates IncTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

Manhattan Associates Inc vs UnitedHealth Group Inc — how do they compare? Manhattan Associates Inc trades at $204.05 (market cap $12.06B), while UnitedHealth Group Inc trades at $379.61 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 27.6× Manhattan Associates Inc's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Manhattan Associates Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Manhattan Associates Inc for 12 Days and UnitedHealth Group Inc for 97 Days on average.

MANHUNH
Market Cap
$12.06B$332.96B
Volume
376,1507,273,749
Sector
TechnologyHealth
52-Week High
$223.76$436.35
52-Week Low
$120.88$259.02
Typical Hold Time
12 Days97 Days
Enterprise Value
$11.93B$374.82B
Dividend Yield
—2.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Manhattan Associates Inc

MANH trades at $205.29, up 1.57% with strong technical momentum and bullish moving average signals. The company demonstrates robust profitability with 18.67% net margins and consistent earnings beats, though valuation metrics remain elevated. Recent news includes product expansion with Editions launch and ongoing legal investigations regarding fiduciary duties.

Outlook remains positive with analyst consensus at Buy and $210.50 target, though risks include high valuation multiples and legal scrutiny. The stock offers growth potential through strong operational performance but faces headwinds from potential governance concerns and competitive pressures in the software sector.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $375.98, showing minor daily weakness but maintaining a bullish technical signal. The company reported strong Q2 2026 earnings, beating estimates, and reaffirmed its full-year outlook. Revenue growth remains robust, though net margins have compressed from prior years. Analyst sentiment is overwhelmingly positive, with a consensus price target of $473.89 implying significant upside.

The outlook for UNH is favorable, driven by earnings momentum and strategic initiatives like AI investment. Key risks include regulatory pressures and medical cost trends. The stock presents a compelling opportunity for investors seeking exposure to a leading healthcare company with solid fundamentals and Wall Street support.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MANH

No sentiment data available yet.

UNH
71% Buy29% Sell
Avg holding period · 97 Days

Top news

Latest headlines on both assets

About Manhattan Associates Inc

Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.

Read more on MANH →

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →